子分类：
| 序号 | 专利名 | 申请号 | 申请日 | 公开（公告）号 | 公开（公告）日 | 发明人 |
|---|---|---|---|---|---|---|
| 61 | Medicinal composition | JP3133087 | 1987-02-13 | JPS62240653A | 1987-10-21 | HARARUDO MASHIYURAA |
| 62 | JPS6215548B2 - | JP15558176 | 1976-12-23 | JPS6215548B2 | 1987-04-08 | HENRII MARUTEIIN |
| 63 | Medicinal composition | JP7644186 | 1986-04-01 | JPS61243052A | 1986-10-29 | ANDORIYUU MARUKOOMU KUREITON; UIRIAMU ANSONII JIEFURII |
| 64 | Amino acid derivative antispasmodic | JP3174286 | 1986-02-15 | JPS61200950A | 1986-09-05 | HARORUDO ERU KOON; DAARERU WATOSON |
| The present invention relates to anticonvulsant compounds useful in the treatment of epilepsy and other central nervous system disorders. The compounds of this invention have the following general formula: |
||||||
| 65 | 9-aminoalkylfluorenes | JP28908585 | 1985-12-20 | JPS61158944A | 1986-07-18 | UIRIAMU BURAIANTO REESUFUIIRUD; RICHIYAADO RII SHIMON |
| 66 | JPS6012347B2 - | JP5161275 | 1975-04-30 | JPS6012347B2 | 1985-04-01 | RAASUROO FUOIAA; AARUPAADO FURUKA; FUERENTSU SHEBESHUTEIEEN; YOORAN HERUCHERU; ERUJEEBETO BENDEIFUI |
| 1504541 Compositions containing amino acid derivatives CHINOIN GYOGYSZER ES VEGYESZETI TERMEKEK GYARA RT 28 April 1975 [29 April 1974 26 March 1975] 17608/75 Heading A5B [Also in Divisions C2 and C3] Cosmetic and pharmaceutical compositions contain (I) and/or salts thereof as active ingredient wherein A<SP>1</SP> stands for hydroxy, C 1-4 alkoxy, cycloalkoxy, aralkoxy, substituted aralkoxy, aryloxy, substituted aryloxy or a group of the general formulae: wherein R<SP>14</SP> is hydrogen, C 1-4 alkyl or aralkyl, R<SP>6</SP> is hydrogen, C 1-5 alkyl, aralkyl, hydroxysubstituted aralkyl, heteroaralkyl or a group of the general formula: Y is hydroxy, amino, alkylamino, dialkylamino, C 1-4 alkoxy or aralkoxy, and r is an integer of from 1 to 10 or an average polymerization grade of up to 2000, B<SP>1</SP> is a group of the formulae -SO 2 OH, -OSO 2 OH, -O-PO(OH) 2 or -S-S-R<SP>11</SP>, wherein R<SP>11</SP> is C 1-4 alkyl, aralkyl or aryl or a residue obtained when removing group B<SP>1</SP> from the general formula (I), R stands for hydrogen, C 1-4 alkyl or aralkyl, R<SP>x</SP> stands for hydrogen or halogen, R<SP>1</SP> stands for hydrogen, C 1-4 alkyl, aryl, aryl having a nitro or alkoxy substituent, aralkyl, substituted aralkyl, alkoxycarbonyl, cycloalkoxycarbonyl, aralkoxycarbonyl, substituted aralkoxycarbonyl having, e.g. a halogen, alkoxy, nitro, phenylazo or alkoxyphenylazo substituent, unsubstituted or substituted aryloxycarbonyl, acyl, arylsulfonyl or group (wherein R<SP>6</SP> has the same meanings as defined above and p is an integer of from 1 to 10 or an average polymerization degree of up to 2000), R<SP>2</SP> stands for hydrogen, C 1-4 alkyl, or aralkyl or R<SP>2</SP> and R<SP>2</SP> may each stand for a -CO- group and form a ring through an o-phenylene, alkylene or -CH=CH- group, R<SP>3</SP> stands for hydrogen, carboxy or carbalkoxy, R<SP>4</SP> stands for hydrogen, halogen, C 1-4 alkyl or hydroxy, R<SP>5</SP> stands for hydrogen, halogen, C 1-4 alkyl, carboxy, carboxamido, carbalkoxy or carboaralkoxy, m is 1, 2 or 3, n is 1, 2, 3 or 4, s is 0, 1, 2, 3 or 4, and t is 1, 2 or 3. | ||||||
| 67 | Diagnostic agent, manufacture and complex salt | JP584984 | 1984-01-18 | JPS59139390A | 1984-08-10 | HAINTSU GURIISU; DOUBUE ROOZENBERUKU; HANSUUYOAHIMU BUAINMAN |
| 68 | Acylanilide, manufacture and antiandrogenic medicinal or veterinary composition | JP13108583 | 1983-07-20 | JPS5933250A | 1984-02-23 | HAWAADO TATSUKAA |
| 69 | JPS593988B2 - | JP1952276 | 1976-02-26 | JPS593988B2 | 1984-01-27 | PURIAN WARUTAA METOKARUFU; MISHERU YUNKU |
| 70 | Novel 3-cyano-propionic acid amide derivative | JP10403982 | 1982-06-18 | JPS58952A | 1983-01-06 | AKUSERU KUREEMAN; YURUGENSU MARUTENSU; HORUSUTO BUAIGERU |
| 71 | JPS5644063B1 - | JP10453571 | 1971-12-22 | JPS5644063B1 | 1981-10-16 | |
| 72 | JPS5641629B1 - | JP9910471 | 1971-12-09 | JPS5641629B1 | 1981-09-29 | |
| 73 | Alphaaaryllalpha*alphaabis*omegaa *disubstituted amino*alkyl*acetoamide and related compound | JP11508979 | 1979-09-07 | JPS5592350A | 1980-07-12 | PIITAA KEI YONAN |
| 74 | Production of 22aminoo *1*2*3*44tetrahydronaphthalene* derivatives | JP6454877 | 1977-05-31 | JPS5318550A | 1978-02-20 | PIEERU BANHOTSUFU; PIEERU KUREERUBUU |
| 75 | 22 amino nn * beetaa hidorokishifuenechiru ** asetoamidoojudotai oyobi soreranoennoseiho | JP7706475 | 1975-06-24 | JPS5119736A | 1976-02-17 | GERUHARUTO TSUERUSU; KARURU ANTON UISUMAIRU |
| 76 | Shinkiaminosanjudotainoseiho | JP5161275 | 1975-04-30 | JPS514121A | 1976-01-14 | RAASUROO FUOIAA; AARUPAADO FURUKA; FUERENTSU SHEBESHUTEIEEN; YOORAN HERUCHERU; ERUJEEBETO BENDEIFUI |
| 1504541 Compositions containing amino acid derivatives CHINOIN GYOGYSZER ES VEGYESZETI TERMEKEK GYARA RT 28 April 1975 [29 April 1974 26 March 1975] 17608/75 Heading A5B [Also in Divisions C2 and C3] Cosmetic and pharmaceutical compositions contain (I) and/or salts thereof as active ingredient wherein A<SP>1</SP> stands for hydroxy, C 1-4 alkoxy, cycloalkoxy, aralkoxy, substituted aralkoxy, aryloxy, substituted aryloxy or a group of the general formulae: wherein R<SP>14</SP> is hydrogen, C 1-4 alkyl or aralkyl, R<SP>6</SP> is hydrogen, C 1-5 alkyl, aralkyl, hydroxysubstituted aralkyl, heteroaralkyl or a group of the general formula: Y is hydroxy, amino, alkylamino, dialkylamino, C 1-4 alkoxy or aralkoxy, and r is an integer of from 1 to 10 or an average polymerization grade of up to 2000, B<SP>1</SP> is a group of the formulae -SO 2 OH, -OSO 2 OH, -O-PO(OH) 2 or -S-S-R<SP>11</SP>, wherein R<SP>11</SP> is C 1-4 alkyl, aralkyl or aryl or a residue obtained when removing group B<SP>1</SP> from the general formula (I), R stands for hydrogen, C 1-4 alkyl or aralkyl, R<SP>x</SP> stands for hydrogen or halogen, R<SP>1</SP> stands for hydrogen, C 1-4 alkyl, aryl, aryl having a nitro or alkoxy substituent, aralkyl, substituted aralkyl, alkoxycarbonyl, cycloalkoxycarbonyl, aralkoxycarbonyl, substituted aralkoxycarbonyl having, e.g. a halogen, alkoxy, nitro, phenylazo or alkoxyphenylazo substituent, unsubstituted or substituted aryloxycarbonyl, acyl, arylsulfonyl or group (wherein R<SP>6</SP> has the same meanings as defined above and p is an integer of from 1 to 10 or an average polymerization degree of up to 2000), R<SP>2</SP> stands for hydrogen, C 1-4 alkyl, or aralkyl or R<SP>2</SP> and R<SP>2</SP> may each stand for a -CO- group and form a ring through an o-phenylene, alkylene or -CH=CH- group, R<SP>3</SP> stands for hydrogen, carboxy or carbalkoxy, R<SP>4</SP> stands for hydrogen, halogen, C 1-4 alkyl or hydroxy, R<SP>5</SP> stands for hydrogen, halogen, C 1-4 alkyl, carboxy, carboxamido, carbalkoxy or carboaralkoxy, m is 1, 2 or 3, n is 1, 2, 3 or 4, s is 0, 1, 2, 3 or 4, and t is 1, 2 or 3. | ||||||
| 77 | JPS4992056A - | JP11275073 | 1973-10-06 | JPS4992056A | 1974-09-03 | |
| 78 | 금속 아미디네이트를 이용한 원자층 증착법 | KR1020177010532 | 2003-11-14 | KR102220703B1 | 2021-02-26 | |
| 79 | 금속 아미디네이트를 이용한 원자층 증착법 | KR1020127014939 | 2003-11-14 | KR101437250B1 | 2014-10-13 | 고든로이지.; 림부영에스. |
| 금속 필름이 균일한 두께 및 우수한 스텝 커버리지로 증착된다. 구리 금속 필름을 가열된 기판에 구리(I) N, N'-디이소프로필아세트아미디네이트 증기와 수소 가스를 교대로 반응시켜서 증착시킨다. 코발트 금속 필름을 가열된 기판에 코발트(II) 비스(N, N'-디이소프로필아세트아미디네이트) 증기와 수소 가스를 교대로 반응시켜서 증착시킨다. 이들 금속의 질화물 및 산화물을 수소를 암모니아 또는 수증기로 각각 교체함으로써 형성할 수가 있다. 필름은 좁은 홀에도 매우 균일한 두께 및 우수한 스텝 커버리지를 갖는다. 적당한 응용분야로는 자기정보 저장장치에서의 마이크로전자 및 자기저항 층의 전기적 상호연결에 사용된다.
|
||||||
| 80 | 금속 아미디네이트를 이용한 원자층 증착법 | KR1020147013244 | 2003-11-14 | KR1020140096288A | 2014-08-05 | 고든로이지.; 림부영에스. |
| 금속 필름이 균일한 두께 및 우수한 스텝 커버리지로 증착된다. 구리 금속 필름을 가열된 기판에 구리(I) N, N'-디이소프로필아세트아미디네이트 증기와 수소 가스를 교대로 반응시켜서 증착시킨다. 코발트 금속 필름을 가열된 기판에 코발트(II) 비스(N, N'-디이소프로필아세트아미디네이트) 증기와 수소 가스를 교대로 반응시켜서 증착시킨다. 이들 금속의 질화물 및 산화물을 수소를 암모니아 또는 수증기로 각각 교체함으로써 형성할 수가 있다. 필름은 좁은 홀에도 매우 균일한 두께 및 우수한 스텝 커버리지를 갖는다. 적당한 응용분야로는 자기정보 저장장치에서의 마이크로전자 및 자기저항 층의 전기적 상호연결에 사용된다.
|
||||||
QQ群二维码
意见反馈
意见反馈